Hoglund, Zachary
Ruiz-Uribe, Nancy
del Sastre, Eric
Woost, Benjamin
Bader, Elizabeth
Bailey, Joshua
Hyman, Bradley T.
Zwang, Theodore
Bennett, Rachel E. http://orcid.org/0000-0001-9640-0575
Funding for this research was provided by:
Alzheimer's Association (23AARG-1029355)
National Institute on Aging (R00AG068602, R00AG061259, P30AG062421)
Ministerio de Ciencia, Innovación y Universidades (FPU18/00630)
Article History
Received: 2 April 2024
Revised: 5 June 2024
Accepted: 5 June 2024
First Online: 17 June 2024
Declarations
:
: BTH has a family member who works at Novartis and owns stock in Novartis; he serves on the SAB of Dewpoint and owns stock. He serves on a scientific advisory board or is a consultant for AbbVie, Avrobio, Axon, Biogen, BMS Cell Signaling, Genentech, Ionis, Novartis, Seer, Takeda, the US Dept of Justice, Vigil, Voyager. His laboratory is supported by Sponsored research agreements with AbbVie, F Prime, and research grants from the Cure Alzheimer's Fund, Tau Consortium, and the JPB Foundation. REB works on the AbbVie-Hyman Collaboration. The other authors declare no competing interests.